Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2024   4,792      
Beginning balance at Mar. 31, 2024 $ (121,498) $ 48 $ 708,027 $ (827,380) $ (2,193)
Increase (Decrease) in Stockholders' Equity          
Net loss (107,347)     (107,347)  
Foreign currency translation adjustments, net (276)       (276)
Shares issued under employee incentive plans, net (in shares)   109      
Shares issued under employee incentive plans, net 0 $ 1 (1)    
Shares issued related to warrants (in shares)   406      
Shares issued related to warrants 30,123 $ 4 30,119    
Stock-based compensation 2,376   2,376    
Ending balance (in shares) at Dec. 31, 2024   5,307      
Ending balance at Dec. 31, 2024 (196,622) $ 53 740,521 (934,727) (2,469)
Beginning balance (in shares) at Sep. 30, 2024   4,792      
Beginning balance at Sep. 30, 2024 (151,104) $ 48 709,667 (859,427) (1,392)
Increase (Decrease) in Stockholders' Equity          
Net loss (75,300)     (75,300)  
Foreign currency translation adjustments, net (1,077)       (1,077)
Shares issued under employee incentive plans, net (in shares)   109      
Shares issued under employee incentive plans, net 0 $ 1 (1)    
Shares issued related to warrants (in shares)   406      
Shares issued related to warrants 30,123 $ 4 30,119    
Stock-based compensation 736   736    
Ending balance (in shares) at Dec. 31, 2024   5,307      
Ending balance at Dec. 31, 2024 $ (196,622) $ 53 740,521 (934,727) (2,469)
Beginning balance (in shares) at Mar. 31, 2025 6,962 6,962      
Beginning balance at Mar. 31, 2025 $ (164,366) $ 70 779,645 (942,471) (1,610)
Increase (Decrease) in Stockholders' Equity          
Net loss (91,505)     (91,505)  
Foreign currency translation adjustments, net 704       704
Shares issued under employee incentive plans, net (in shares)   121      
Shares issued under employee incentive plans, net 81   80    
Shares issued related to the SEPA, net (in shares)   7,052      
Shares issued related to the SEPA, (net of $804 issuance costs) 72,031 $ 70 71,961    
Stock-based compensation $ (1,174)   (1,174)    
Ending balance (in shares) at Dec. 31, 2025 14,135 14,135      
Ending balance at Dec. 31, 2025 $ (184,229) $ 141 850,512 (1,033,976) (906)
Beginning balance (in shares) at Sep. 30, 2025   13,333      
Beginning balance at Sep. 30, 2025 (160,499) $ 133 846,451 (1,006,133) (950)
Increase (Decrease) in Stockholders' Equity          
Net loss (27,843)     (27,843)  
Foreign currency translation adjustments, net 44       44
Shares issued under employee incentive plans, net (in shares)   70      
Shares issued under employee incentive plans, net 0 $ 1 (1)    
Shares issued related to the SEPA, net (in shares)   732      
Shares issued related to the SEPA, (net of $804 issuance costs) 5,038 $ 7 5,031    
Stock-based compensation $ (969)   (969)    
Ending balance (in shares) at Dec. 31, 2025 14,135 14,135      
Ending balance at Dec. 31, 2025 $ (184,229) $ 141 $ 850,512 $ (1,033,976) $ (906)